Cardiovascular Mortality Recruiting Phase 4 Trials for Clopidogrel (DB00758)

Also known as: Cardiovascular Death / Cardiac Death

IndicationStatusPhase
DBCOND0040959 (Cardiovascular Mortality)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02446730Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary SyndromeTreatment